索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]韩红丹,郭宏.超正常化血管衰老的研究进展[J].国际心血管病杂志,2021,05:274-276.
点击复制

超正常化血管衰老的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年05期
页码:
274-276
栏目:
综述
出版日期:
2021-10-01

文章信息/Info

Title:
-
作者:
韩红丹;郭宏
150001 哈尔滨医科大学附属第一医院
Author(s):
-
关键词:
血管衰老;  超正常化血管;  早期血管衰老
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.05.005
文献标识码:
-
摘要:
血管衰老是与增龄相关的动脉壁硬度增加现象。动脉结构和功能的过早改变引起的早期血管衰老,是血管衰老的一种极端表型。超正常化血管是近年发现另一种极端表型,即与年龄不相符的异常低的动脉硬度。这种极端表型为研究血管衰老的保护机制提供了新途径。该文介绍了超正常化血管衰老的人群特点、发生机制、筛查识别等。
Abstract:
-

参考文献/References

[1] Ungvari Z, Tarantini S, Sorond F, et al. Mechanisms of vascular aging, a geroscience perspective: JACC Focus Seminar[J]. J Am Coll Cardiol, 2020, 75(8):931-941.
[2] Antza C, Doundoulakis I, Natsis M,et al. Treatment of early vascular ageing[J]. Curr Pharm Des, 2018, 24(37):4385-4390.
[3] Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension[J]. Lancet, 2016, 388(10060):2665-2712.
[4] Bruno RM, Nilsson PM, Engstr?m G, et al. Early and supernormal vascular aging: clinical characteristics and association with incident cardiovascular events[J]. Hypertension, 2020, 76(5):1616-1624.
[5] Laurent S, Boutouyrie P, Cunha PG,et al. Concept of extremes in vascular aging[J]. Hypertension, 2019, 74(2):218-228.
[6] Lemogoum D, Ngatchou W, Janssen C, et al. Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies[J]. Hypertension, 2012, 60(1):123-128.
[7] Grimes KM, Reddy AK, Lindsey ML, et al. And the beat goes on: maintained cardiovascular function during aging in the longest-lived rodent, the naked mole-rat[J]. Am J Physiol Heart Circ Physiol, 2014, 307(3):H284-H291.
[8] Jiang JJ, Cheng LH, Wu H, et al. Insights into long noncoding RNAs of naked mole rat(heterocephalus glaber)and their potential association with cancer resistance[J]. Epigenetics Chromatin, 2016, 9:51.
[9] Jin J, Liu Y, Huang L, Tan H. Advances in epigenetic regulation of vascular aging[J]. Rev Cardiovasc Med, 2019, 20(1):19-25.
[10] Ding YN, Tang X, Chen HZ, et al. Epigenetic regulation of vascular aging and age-related vascular diseases[J]. Adv Exp Med Biol, 2018, 1086:55-75.
[11] Ungvari Z, Tarantini S, Nyúl-Tóth á, et al. Nrf2 dysfunction and impaired cellular resilience to oxidative stressors in the aged vasculature: from increased cellular senescence to the pathogenesis of age-related vascular diseases[J]. Geroscience, 2019, 41(6):727-738.
[12] Lewis KN, Wason E, Edrey YH, et al, Buffenstein R. Regulation of Nrf2 signaling and longevity in naturally long-lived rodents[J]. Proc Natl Acad Sci U S A, 2015, 112(12):3722-3727.
[13] Zhou T, Zhang M, Zhao L, et al. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin Ⅱ-induced vascular smooth muscle cell senescence[J]. Am J Physiol Cell Physiol, 2016, 311(4):C572-C582.
[14] Antza C, Doundoulakis I, Akrivos E, et al. Estimated arterial stiffness and prediction of vascular aging: the rising of a new era[J]. Curr Pharm Des, 2021, 27(16):1871-1877.
[15] Cunha PG, Boutouyrie P, Nilsson PM,et al. Early vascular ageing(EVA): definitions and clinical applicability[J]. Curr Hypertens Rev, 2017, 13(1):8-15.
[16] Niiranen TJ, Lyass A, Larson MG, et al. Prevalence, correlates, and prognosis of healthy vascular aging in a western community-dwelling cohort: the Framingham Heart Study[J]. Hypertension, 2017, 70(2):267-274.
[17] 陈雅筝, 李澄, 朱梦颖, 等. 颅内动脉粥样硬化的高分辨力血管壁成像特征及临床应用[J]. 国际医学放射学杂志, 2019, 42(3):290-294.
[18] Cavalcante JL, Lima JA, Redheuil A,et al. Aortic stiffness: current understanding and future directions[J]. J Am Coll Cardiol, 2011, 57(14):1511-22.
[19] Grotenhuis HB, Westenberg JJ, Steendijk P, et al. Validation and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI[J]. J Magn Reson Imaging, 2009, 30(3):521-526.
[20] Greve SV, Blicher MK, Kruger R, et al. Elevated estimated arterial age is associated with metabolic syndrome and low-grade inflammation[J]. J Hypertens, 2016, 34(12):2410-2417.
[21] Agostino RB, Sr ARB, Vasan RS, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study[J]. Circulation, 2008, 117(6):743-53.
[22] Groenewegen KA, den Ruijter HM, Pasterkamp G, et al. Vascular age to determine cardiovascular disease risk: a systematic review of its concepts, definitions, and clinical applications[J]. Eur J Prev Cardiol, 2016, 23(3):264-274.
[23] Reference Values for Arferral Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ’establishing normal and reference values’[J]. Eur Heart J, 2010, 31(19):2338-2350.
[24] Greve SV, Blicher MK, Kruger R, et al. Estimated carotid-femoral pulse wave velocity has similar predictive value as measured carotid-femoral pulse wave velocity[J]. J Hypertens, 2016, 34(7):1279-1289.

备注/Memo

备注/Memo:
通信作者:郭宏,E-mail:guohong2004@163.com
更新日期/Last Update: 2021-10-01